(Q34463183)

2 August 2017

1 reference

title

Treatment of hyperthyroidism with radioactive iodine. (English)

1 reference

2 August 2017

1 reference

1 reference

Kaplan MM

1

1 reference

PubMed ID

9534037

2 August 2017

Meier DA

series ordinal

2

1 reference

PubMed ID

9534037

2 August 2017

Dworkin HJ

series ordinal

3

1 reference

2 August 2017

1 March 1998

1 reference

Endocrinology and Metabolism Clinics of North America

2 August 2017

1 reference

2 August 2017

27

1 reference

2 August 2017

1

1 reference

2 August 2017

205-223

1 reference

The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Pathogenesis of Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioactive iodine therapy for progressive malignant exophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine and thyroid disease: the beginning

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Discontinuing Antithyroid Drug Therapy before Ablation with Radioiodine in Graves Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Antithyroid Drugs and Radioiodine Therapy: A Grain of (Iodized) Salt

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but....

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Choice of therapy in young adults with hyperthyroidism of Graves' disease. A brief, case-directed poll of fifty-four thyroidologists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radiation dose in the selection of 131I or surgical treatment for toxic thyroid adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine treatment of Graves' disease. An assessment of its potential risks

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Late consequences of radioiodine for diagnosis and therapy in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Diuretic Augmentation of 131I Uptake in Inoperable Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Evaluation of early (5 to 6 hours) iodine 123 uptake for diagnosis and treatment planning in Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

The accumulation of radioactive iodine by human fetal thyroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

1 reference

7 January 2021

Radioiodine for nontoxic multinodular goiter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Large, compressive goiters treated with radioiodine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Low iodine diet in I-131 ablation of thyroid remnants.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine-induced thyroid storm. Case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Morbidity, mortality, and quality of life for patients treated with levothyroxine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Treatment of hyperthyroidism with a large initial dose of sodium iodide I 131

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine and the treatment of hyperthyroidism: the early history

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Acute effect of inorganic iodide after 131I therapy for hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Acute changes in thyroid function in patients treated with radioactive iodine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Current Trends in the Management of Graves' Disease*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

Intentional radioiodine ablation in Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970307-8

7 January 2021

10.1016/S0889-8529(05)70307-8

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

9534037